search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
MEMBERNEWS


SureScreen releases coronavirus test


Derby-based rapid diagnostics and laboratory screening company SureScreen Diagnostics has launched a rapid test for coronavirus. The product is easy to use -


needing only finger prick capillary blood to function - and provides a result in ten minutes, a significant improvement compared to laboratory testing methods.


‘As a company focused on innovation in diagnostics, this product is what we are about’


Director David Campbell said:


“The ease of use of the test, the low cost and the speed of results, means that more effective screening can be put into place, and we can significantly reduce further infections going forward.” The company is working with the


NHS and the Department of Health in setting up screening best practice for the UK, as well as


exporting the product all over the world. Since the test can detect a positive result within three-to- seven days after infection, it is seen as a big step forward in being able to contain the virus. The test works much like a


pregnancy test, whereby antibodies are designed to target the blood specimen infected with the virus. The presence or absence of the lines on the test indicate the result. The compact product can be read by eye, without the need for big machinery. David added: “We’re delighted


to be launching a test that can help with screening and containing the coronavirus. We are hearing from clients that the laboratories are overrun with samples waiting for screening, meanwhile people are having to be isolated which is a big issue for the healthcare providers and the individuals. We hope that this test will be able to alleviate this issue and provide robust screening at the point of care.”


12 business network April 2020


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96